View in EDS

Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.

Saved in:
Bibliographic Details
Title: Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Authors: Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR
Source: Cancer treatment reports [Cancer Treat Rep] 1983 May; Vol. 67 (5), pp. 413-9.
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: National Cancer Institute [etc.] Country of Publication: United States NLM ID: 7607107 Publication Model: Print Cited Medium: Print ISSN: 0361-5960 (Print) Linking ISSN: 03615960 NLM ISO Abbreviation: Cancer Treat Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 6342771
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liebman+HA%22">Liebman HA</searchLink><br /><searchLink fieldCode="AU" term="%22Hum+GJ%22">Hum GJ</searchLink><br /><searchLink fieldCode="AU" term="%22Sheehan+WW%22">Sheehan WW</searchLink><br /><searchLink fieldCode="AU" term="%22Ryden+VM%22">Ryden VM</searchLink><br /><searchLink fieldCode="AU" term="%22Bateman+JR%22">Bateman JR</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227607107%22">Cancer treatment reports</searchLink> [Cancer Treat Rep] 1983 May; Vol. 67 (5), pp. 413-9.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22National+Cancer+Institute+[etc%2E]%22">National Cancer Institute [etc.] </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7607107 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0361-5960 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203615960%22">03615960 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Treat Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=6342771
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 413
    Titles:
      – TitleFull: Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liebman HA
      – PersonEntity:
          Name:
            NameFull: Hum GJ
      – PersonEntity:
          Name:
            NameFull: Sheehan WW
      – PersonEntity:
          Name:
            NameFull: Ryden VM
      – PersonEntity:
          Name:
            NameFull: Bateman JR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 1983 May
              Type: published
              Y: 1983
          Identifiers:
            – Type: issn-print
              Value: 0361-5960
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cancer treatment reports
              Type: main
ResultId 1